LN002

LN002 is a small molecule research compound that acts as an orally bioavailable inhibitor targeting the Cryptosporidium oxidase. It is employed in studies of cryptosporidiosis, facilitating both in vitro assays and in vivo animal model research to investigate parasitic infection mechanisms and potential therapeutic strategies.